On Monday, a Pfizer executive appeared before European lawmakers and admitted the corporation had not tested the COVID vaccine’s ability to stop transmission.
The stunning comments were made by Janine Small, the company’s president of international developed markets, as she was testifying before the EU. Rob Roos, EU Parliament member asked if the experimental mRNA vaccine had been tested for blocking transmission of COVID.
Small responded by saying, “Regarding the question around, uh, did we know about stopping the immunization before it entered the market? No.”
She went on to justify the company’s lack of transparency by saying, “We had to really move at the speed of science to really understand what is taking place in the market, and from that point of view we had to do everything at risk.”
Roos responded to her claims by getting back to the matter that concerns most people who experienced the severity of COVID mandates and lockdowns by saying, “Millions of people worldwide felt forced to get vaccinated because of the myth that ‘you do it for others. Now, this turned out to be a cheap lie. This should be exposed.”
“Get vaccinated for others” was always a lie.
The only purpose of the #COVID passport: forcing people to get vaccinated.
The world needs to know. Share this video! ⤵️ pic.twitter.com/su1WqgB4dO
— Rob Roos MEP 🇳🇱 (@Rob_Roos) October 11, 2022
The admission raises questions regarding the recommendations and actions taken by officials to persuade, and oftentimes forced, free citizens to take the experimental vaccine.
However, Pfizer maintains that they think the vaccine does help people survive the effects of COVID, and could help prevent the transmission of the disease. The executive cited a controversial study conducted by the Imperial College of London.
The study said vaccines helped save almost twenty million lives. However, the modeling used in the study has come under question by peers within the industry. However, the study was used as governmental justification for completely shutting down the economy during the pandemic.